Antitrust United States | 26 May 2023
Contents: - Viasat wins unconditional EU antitrust approval to acquire Inmarsat - Boston Scientific nixes acquisition of M.I.Tech - Gilead, Teva defend HIV drug agreement as US pay-for-delay antitrust trial opens - Viterra in talks...To view the full article, register now.
Already a subscriber? Click here to view full article